Despite advanced surgical techniques, meniscus repair remains a significant clinical challenge due to high failure rates and chronic disability among…
See where grants have been awarded across Minnesota.
Daniel Saris, MD, PhD
2024-2026
John Hulleman, PhD
Age-related macular degeneration (AMD) is the leading cause of blindness in the industrialized world. Although variants in two genes—ARMS2/HTRA1—are…
2024-2026
Marija Cvetanovic, PhD
Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease with no disease modifying treatments or therapies available…
2024-2026
Zhe Chen, PhD
Vision impairment that results from optic nerve damage, such as from glaucoma, poses a significant challenge to public health. To date, there are no…
2024-2026
Patrick Walsh, MS
Anatomic, a University of Minnesota start-up company based in Minnesota, develops neural tissues used in basic science and drug development. Its…
2024-2026
Michael Barry, PhD
Propionic acidemia (PA) is a severe metabolic disorder caused by mutations in the PCCA gene. Traditional treatments, including stringent life-long…
2024-2028
Diana Trujillo, PhD
Our goal with this grant is to push innovation to increase yield and lower production cost for targeted proteins, using molecular farming.…
2022-2023
Wesley Wierson, PhD
LEAH Labs is an innovative biotech startup headquartered at Mayo Clinic's 'Hatchery Lab' developing regenerative cell therapies, first focused on…
2022-2023
Richard Murphy
This project aims to develop and implant a preclinical model of a regenerative tissue tube for nerve repair. The TRUE™ Tissue allogeneic biomaterial…
2022-2023
Ross Dunbar
1) Build and test a customer demonstration model of the liquid nitrogen-free cryogenic storage system. This system will allow storage and…
2022-2023
Maria Athanasiou, PhD
We are developing a one-time treatment for durable remission of HIV, after which patients will no longer need to take traditional antiretroviral…
2022-2023
Ferenc Toth, DVM, PhD
Our ultimate goal is to bring our chondrocyte product, harvested from human induced pluripotent cell derived multi tissue organoids, into human…
2022-2024